Study Title and Description
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Key Questions Addressed
|4||Indirect Evidence (Systematic Reviews): KQ 2 - What are the (comparative) benefits and harms of interventions to treat acute attacks of primary headache in women who are pregnant (or attempting to become pregnant), postpartum, or breastfeeding?|
Primary Publication Information
|Title||Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.|
|Author||Hamulyák EN., Scheres LJ., Marijnen MC., Goddijn M., Middeldorp S.|
|Country||Department of Vascular Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.|
Pubmed ID: 32358837
Secondary Publication Information
There are currently no secondary publications defined for this study.
Extraction Form: Extraction Form for Indirect Evidence (Systematic Reviews)
No arms have been defined in this extraction form.
|Question... Follow Up||Answer||Follow-up Answer|
|How many DATABASES did the authors search?||4|
|What was the YEAR of the last search?||2019|
|How many STUDIES were included in the review?||11|
|What INTERVENTIONS were addressed?||NSAIDs|
|Aspirin (Low dose)|
|Were MATERNAL adverse events reported?||Yes|
|Were FETAL/CHILD adverse events reported?||Yes|
|AMSTAR Item 1 - Did the authors specify the research questions and inclusion criteria for the SR?||Yes|
|AMSTAR Item 4 - Did the SR authors use a comprehensive literature search strategy?||Yes|
|AMSTAR Item 5 - Did the SR authors perform study selection in duplicate?||Yes|
|AMSTAR Item 6 - Did the SR authors perform data extraction in duplicate, either independently or through verification?||Yes|
|AMSTAR Item 8 - Did the SR authors describe the included studies in adequate detail?||Yes|
|AMSTAR Item 9 - Did the SR authors use a satisfactory technique for assessing the risk of bias in individual studies that were included in the SR?||Yes|
|AMSTAR Item 12 - Did the SR authors assess the potential impact of risk of bias in individual studies on the summary results, interpretation, discussion?||Yes|
|AMSTAR Item 11 - If meta-analysis (MA) was performed did the SR authors use appropriate methods for statistical combination of results?||Yes|
|AMSTAR Item 14 - Did the SR authors provide a satisfactory explanation for, and discussion of, any heterogeneity observed in the results of the SR?||Yes|
|AMSTAR Item 16 - Did the SR authors report the lack of significant potential of conflict of interest (COI) regarding conducting the SR?||Yes|
|What was the OVERALL QUALITY OF THE SYSTEMATIC REVIEW||High|
|MATERNAL Adverse Events - ANTEPARTUM||1|
|MATERNAL Adverse Events - POSTPARTUM|
|MATERNAL Adverse Events - DELIVERY|
|MATERNAL Adverse Events - TIMING NOT REPORTED|
|FETAL/CHILD Adverse Events - IN UTERO|
|FETAL/CHILD Adverse Events - PERINATAL|
|FETAL/CHILD Adverse Events - NEONATAL||1|
|FETAL/CHILD Adverse Events - CHILD|
No baseline characteristics have been defined for this extraction form.
Results & Comparisons
No Results found.
|Arm or Total||Title||Description||Comments|
No quality dimensions were specified.
No quality rating data was found.